Literature DB >> 26471844

Emerging Functional Divergence of β-Arrestin Isoforms in GPCR Function.

Ashish Srivastava1, Bhagyashri Gupta1, Charu Gupta1, Arun K Shukla2.   

Abstract

G protein-coupled receptors (GPCRs) are tightly regulated by multifunctional protein β-arrestins. Two isoforms of β-arrestin sharing more than 70% sequence identity and overall very similar 3D structures, β-arrestins 1 and 2, were originally expected to be functionally redundant. However, in recent years multiple lines of emerging evidence suggest they have distinct roles in various aspects of GPCR regulation and signaling. We summarize selected examples of GPCRs where β-arrestin isoforms are discovered to display non-overlapping and sometimes even antagonistic functions. We also discuss potential mechanistic basis for their functional divergence and highlight new frontiers that are likely to form the focal points of research in this area in coming years.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptors; arrestin; biased agonism; cellular signaling; desensitization; mitogen-activated protein kinase.

Mesh:

Substances:

Year:  2015        PMID: 26471844     DOI: 10.1016/j.tem.2015.09.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  57 in total

1.  CCR2 Signaling Selectively Regulates IFN-α: Role of β-Arrestin 2 in IFNAR1 Internalization.

Authors:  Dionna W Williams; Lauren C Askew; Elonna Jones; Janice E Clements
Journal:  J Immunol       Date:  2018-11-30       Impact factor: 5.422

Review 2.  Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors.

Authors:  Madhu Chaturvedi; Justin Schilling; Alexandre Beautrait; Michel Bouvier; Jeffrey L Benovic; Arun K Shukla
Journal:  Trends Biochem Sci       Date:  2018-05-04       Impact factor: 13.807

3.  Conformational Sensors and Domain Swapping Reveal Structural and Functional Differences between β-Arrestin Isoforms.

Authors:  Eshan Ghosh; Hemlata Dwivedi; Mithu Baidya; Ashish Srivastava; Punita Kumari; Tomek Stepniewski; Hee Ryung Kim; Mi-Hye Lee; Jaana van Gastel; Madhu Chaturvedi; Debarati Roy; Shubhi Pandey; Jagannath Maharana; Ramon Guixà-González; Louis M Luttrell; Ka Young Chung; Somnath Dutta; Jana Selent; Arun K Shukla
Journal:  Cell Rep       Date:  2019-09-24       Impact factor: 9.423

4.  Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1.

Authors:  Zhiyuan Ma; Yen-Rei Yu; Cristian T Badea; Jeffrey J Kovacs; Xinyu Xiong; Suzy Comhair; Claude A Piantadosi; Sudarshan Rajagopal
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

Review 5.  Function and therapeutic potential of G protein-coupled receptors in epididymis.

Authors:  Daolai Zhang; Yanfei Wang; Hui Lin; Yujing Sun; Mingwei Wang; Yingli Jia; Xiao Yu; Hui Jiang; Wenming Xu; Jin-Peng Sun; Zhigang Xu
Journal:  Br J Pharmacol       Date:  2020-10-29       Impact factor: 8.739

Review 6.  Structure and dynamics of GPCR signaling complexes.

Authors:  Daniel Hilger; Matthieu Masureel; Brian K Kobilka
Journal:  Nat Struct Mol Biol       Date:  2018-01-08       Impact factor: 15.369

Review 7.  GPCR desensitization: Acute and prolonged phases.

Authors:  Sudarshan Rajagopal; Sudha K Shenoy
Journal:  Cell Signal       Date:  2017-01-28       Impact factor: 4.315

8.  Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.

Authors:  Yubo Cao; Sahil Kumar; Yoon Namkung; Laurence Gagnon; Aaron Cho; Stéphane A Laporte
Journal:  J Biol Chem       Date:  2020-07-23       Impact factor: 5.157

9.  Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3.

Authors:  Jialei Zhu; Zhaoli Hu; Xiaojuan Han; Dongshuo Wang; Qingling Jiang; Jianhua Ding; Ming Xiao; Cong Wang; Ming Lu; Gang Hu
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

10.  Pyrimidinyl Biphenylureas Act as Allosteric Modulators to Activate Cannabinoid Receptor 1 and Initiate β-Arrestin-Dependent Responses.

Authors:  Caitlin A D Jagla; Caitlin E Scott; Yaliang Tang; Changjiang Qiao; Gabriel E Mateo-Semidey; Guillermo A Yudowski; Dai Lu; Debra A Kendall
Journal:  Mol Pharmacol       Date:  2018-10-15       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.